Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism

Saved in:

Bibliographic Details
Published in:	The European journal of contraception & reproductive health care Vol. 18; no. 3; pp. 143 - 147
Main Authors:	Bitzer, Johannes, Amy, Jean-Jacques, Beerthuizen, Rob, Birkhäuser, Martin, Bombas, Teresa, Creinin, Mitchell, Darney, Philip D, Vicente, Lisa Ferreira, Gemzell-Danielsson, Kristina, Imthurn, Bruno, Jensen, Jeffrey T, Kaunitz, Andrew M, Kubba, Ali, Lech, Medard M, Mansour, Diana, Merki, Gabriele, Rabe, Thomas, Sedlecki, Katarina, Serfaty, David, Seydoux, Jacques, Shulman, Lee P, Sitruk-Ware, Regine, Skouby, Sven O, Szarewski, Anne, Trussell, James, Westhoff, Carolyn
Format:	Journal Article
Language:	English
Published:	England Informa Healthcare 01-06-2013 Taylor & Francis
Subjects:	Contraceptives, Oral, Combined - adverse effects Contraceptives, Oral, Hormonal - adverse effects Cyproterone Acetate - adverse effects Europe Female Humans Progestins - adverse effects Risk Assessment Venous Thromboembolism - chemically induced Women's Health Europe
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	1362-5187 1473-0782
DOI:	10.3109/13625187.2013.792637